1-3 of 3
Anna Guidetti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phenotypic Composition of Commercial Anti-CD19 CAR T Cells Affects In Vivo Expansion and Disease Response in Patients with Large B-cell Lymphoma

Chiara Monfrini, Federico Stella, Vanessa Aragona, Martina Magni, Silva Ljevar, Cristina Vella, Eugenio Fardella, Annalisa Chiappella, Francesca Nanetti, Martina Pennisi, Anna Dodero, Anna Guidetti, Paolo Corradini, Cristiana Carniti
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (15): 3378–3386.
https://doi.org/10.1158/1078-0432.CCR-22-0164
Published: 02 August 2022
View article titled, Phenotypic Composition of Commercial Anti-CD19 CAR T Cells Affects <em>In Vivo</em> Expansion and Disease Response in Patients with Large B-cell Lymphoma
Open the PDF for Phenotypic Composition of Commercial Anti-CD19 CAR T Cells Affects <em>In Vivo</em> Expansion and Disease Response in Patients with Large B-cell Lymphoma in another window
Includes: Supplementary data
Journal Articles

Phase II Study of Perifosine and Sorafenib Dual-Targeted Therapy in Patients with Relapsed or Refractory Lymphoproliferative Diseases

Anna Guidetti, Carmelo Carlo-Stella, Silvia L. Locatelli, Walter Malorni, Roberta Mortarini, Simonetta Viviani, Domenico Russo, Alfonso Marchianò, Roberto Sorasio, Anna Dodero, Lucia Farina, Laura Giordano, Massimo Di Nicola, Andrea Anichini, Paolo Corradini, Alessandro M. Gianni
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (22): 5641–5651.
https://doi.org/10.1158/1078-0432.CCR-14-0770
Published: 13 November 2014
View article titled, Phase II Study of Perifosine and Sorafenib Dual-Targeted Therapy in Patients with Relapsed or Refractory Lymphoproliferative Diseases
Open the PDF for Phase II Study of Perifosine and Sorafenib Dual-Targeted Therapy in Patients with Relapsed or Refractory Lymphoproliferative Diseases in another window
Includes: Supplementary data
Journal Articles

Boosting T Cell-Mediated Immunity to Tyrosinase by Vaccinia Virus-Transduced, CD34+-Derived Dendritic Cell Vaccination: A Phase I Trial in Metastatic Melanoma

Massimo Di Nicola, Carmelo Carlo-Stella, Roberta Mortarini, Paola Baldassari, Anna Guidetti, Gian Francesco Gallino, Michele Del Vecchio, Fernando Ravagnani, Michele Magni, Paul Chaplin, Natale Cascinelli, Giorgio Parmiani, Alessandro M. Gianni, Andrea Anichini
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (16): 5381–5390.
https://doi.org/10.1158/1078-0432.CCR-04-0602
Published: 24 August 2004
View article titled, Boosting T Cell-Mediated Immunity to Tyrosinase by Vaccinia Virus-Transduced, CD34<sup>+</sup>-Derived Dendritic Cell Vaccination: <subtitle>A Phase I Trial in Metastatic Melanoma</subtitle>
Open the PDF for Boosting T Cell-Mediated Immunity to Tyrosinase by Vaccinia Virus-Transduced, CD34<sup>+</sup>-Derived Dendritic Cell Vaccination: <subtitle>A Phase I Trial in Metastatic Melanoma</subtitle> in another window